US 5,908,835 AGranted

Anti-tumor compositions containing taxane derivatives

AssigneeRhone-Poulenc Rorer S.A.

InventorMarie-Christine Bissery

Life of this patent

Estimating the term…

Abstract

Disclosed are antitumor compositions comprising taxol, taxotere or their derivatives in combination with an anthracycline antibiotic, the combination having a pharmacologic activity greater than the expected additive effect of its individual components.

Claims5

Dependent claims

A pharmaceutical composition having therapeutic synergy comprising at least one taxane selected from the group consisting of taxol, Taxotere and derivatives thereof in combination with an effective amount of at least one anthracycline antibiotic.

Dependencies are inferred from the claim text.

Facts

Application: 08/967,036Filed 10 Nov 1997 · division
Priority: FR 92 1352510 Nov 1992
Granted: 1 Jun 1999
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/335
Heterocyclic compounds: having oxygen as the only ring hetero atom, e.g. fungichromin
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol
A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…

Family

Serial424,470Parent of this division
US 5,908,835 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results